Pfizer Inc. (PFE), headquartered in New York, discovers, develops, manufactures, markets, distributes, and sells ...

Unfortunately, that's been the case for longer term Pfizer Inc. (NYSE:PFE) shareholders, since the share price is down 55% in ...

The company disclosed revenue of $13.7 billion and adjusted earnings of $0.92 per share, compared to consensus estimates of ...

Pfizer CEO says tariffs are discouraging the company from investing in the US. Pfizer's full-year guidance does not factor in ...

Full-Year 2025 Revenue Guidance: $61.0 to $64.0 billion. Full-Year 2025 Adjusted Diluted EPS Guidance: $2.80 to $3.00. Pfizer ...

Reviewing PFE’s five-year history, the stock has experienced a balanced 50-50 distribution of positive and negative returns after earnings releases.

These household names and index components are yielding better than 4.5% with compelling valuations.

Get insights into Pfizer's Q1 earnings, including challenges like patent expiries & pricing controls, and discover why ...

Pfizer Inc (NYSE: PFE) has reported first-quarter revenue that missed Wall Street estimates, although the drugmaker backed ...